nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—AOX1—Methotrexate—stomach cancer	0.32	0.425	CbGbCtD
Pyrazinamide—XDH—Doxorubicin—stomach cancer	0.286	0.38	CbGbCtD
Pyrazinamide—CYP1A2—Fluorouracil—stomach cancer	0.0654	0.0869	CbGbCtD
Pyrazinamide—CYP3A4—Irinotecan—stomach cancer	0.0357	0.0474	CbGbCtD
Pyrazinamide—CYP3A4—Docetaxel—stomach cancer	0.0262	0.0348	CbGbCtD
Pyrazinamide—CYP3A4—Doxorubicin—stomach cancer	0.0195	0.0259	CbGbCtD
Pyrazinamide—Rash maculo-papular—Floxuridine—stomach cancer	0.00521	0.0381	CcSEcCtD
Pyrazinamide—Photosensitivity—Floxuridine—stomach cancer	0.00474	0.0346	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Floxuridine—stomach cancer	0.00328	0.024	CcSEcCtD
Pyrazinamide—Hepatomegaly—Irinotecan—stomach cancer	0.00276	0.0202	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Floxuridine—stomach cancer	0.00233	0.017	CcSEcCtD
Pyrazinamide—Malaise—Floxuridine—stomach cancer	0.00226	0.0165	CcSEcCtD
Pyrazinamide—Discomfort—Floxuridine—stomach cancer	0.00211	0.0154	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Floxuridine—stomach cancer	0.002	0.0146	CcSEcCtD
Pyrazinamide—Anorexia—Floxuridine—stomach cancer	0.00195	0.0143	CcSEcCtD
Pyrazinamide—Hepatomegaly—Capecitabine—stomach cancer	0.00185	0.0135	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Mitomycin—stomach cancer	0.00183	0.0133	CcSEcCtD
Pyrazinamide—Decreased appetite—Floxuridine—stomach cancer	0.00178	0.013	CcSEcCtD
Pyrazinamide—Malaise—Mitomycin—stomach cancer	0.00177	0.013	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Docetaxel—stomach cancer	0.00175	0.0128	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Fluorouracil—stomach cancer	0.0017	0.0124	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Capecitabine—stomach cancer	0.00169	0.0124	CcSEcCtD
Pyrazinamide—Feeling abnormal—Floxuridine—stomach cancer	0.00169	0.0123	CcSEcCtD
Pyrazinamide—Coagulopathy—Capecitabine—stomach cancer	0.00168	0.0123	CcSEcCtD
Pyrazinamide—Discomfort—Mitomycin—stomach cancer	0.00165	0.0121	CcSEcCtD
Pyrazinamide—Body temperature increased—Floxuridine—stomach cancer	0.00162	0.0118	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Mitomycin—stomach cancer	0.00157	0.0115	CcSEcCtD
Pyrazinamide—Photosensitivity—Fluorouracil—stomach cancer	0.00155	0.0113	CcSEcCtD
Pyrazinamide—Anorexia—Mitomycin—stomach cancer	0.00153	0.0112	CcSEcCtD
Pyrazinamide—Hypersensitivity—Floxuridine—stomach cancer	0.00151	0.011	CcSEcCtD
Pyrazinamide—Decreased appetite—Mitomycin—stomach cancer	0.0014	0.0102	CcSEcCtD
Pyrazinamide—AOX1—gall bladder—stomach cancer	0.00138	0.173	CbGeAlD
Pyrazinamide—Feeling abnormal—Mitomycin—stomach cancer	0.00132	0.00967	CcSEcCtD
Pyrazinamide—Vomiting—Floxuridine—stomach cancer	0.0013	0.00951	CcSEcCtD
Pyrazinamide—Rash—Floxuridine—stomach cancer	0.00129	0.00943	CcSEcCtD
Pyrazinamide—Dermatitis—Floxuridine—stomach cancer	0.00129	0.00942	CcSEcCtD
Pyrazinamide—Hepatomegaly—Epirubicin—stomach cancer	0.00129	0.00941	CcSEcCtD
Pyrazinamide—Body temperature increased—Mitomycin—stomach cancer	0.00127	0.00927	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Methotrexate—stomach cancer	0.00126	0.00921	CcSEcCtD
Pyrazinamide—Nausea—Floxuridine—stomach cancer	0.00122	0.00888	CcSEcCtD
Pyrazinamide—Hepatomegaly—Doxorubicin—stomach cancer	0.00119	0.0087	CcSEcCtD
Pyrazinamide—Photosensitivity—Capecitabine—stomach cancer	0.00108	0.0079	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Fluorouracil—stomach cancer	0.00107	0.00783	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Methotrexate—stomach cancer	0.00105	0.00767	CcSEcCtD
Pyrazinamide—Vomiting—Mitomycin—stomach cancer	0.00102	0.00746	CcSEcCtD
Pyrazinamide—Rash—Mitomycin—stomach cancer	0.00101	0.0074	CcSEcCtD
Pyrazinamide—Dermatitis—Mitomycin—stomach cancer	0.00101	0.00739	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Methotrexate—stomach cancer	0.000992	0.00725	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Epirubicin—stomach cancer	0.000982	0.00718	CcSEcCtD
Pyrazinamide—Nausea—Mitomycin—stomach cancer	0.000954	0.00697	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Epirubicin—stomach cancer	0.000928	0.00678	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Doxorubicin—stomach cancer	0.000909	0.00664	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Doxorubicin—stomach cancer	0.000859	0.00627	CcSEcCtD
Pyrazinamide—XDH—digestive system—stomach cancer	0.000854	0.107	CbGeAlD
Pyrazinamide—Rash maculo-papular—Epirubicin—stomach cancer	0.000828	0.00605	CcSEcCtD
Pyrazinamide—Photosensitivity—Methotrexate—stomach cancer	0.000805	0.00588	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Irinotecan—stomach cancer	0.000793	0.00579	CcSEcCtD
Pyrazinamide—Malaise—Irinotecan—stomach cancer	0.00077	0.00563	CcSEcCtD
Pyrazinamide—Dysuria—Capecitabine—stomach cancer	0.000767	0.00561	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Doxorubicin—stomach cancer	0.000766	0.0056	CcSEcCtD
Pyrazinamide—Photosensitivity—Epirubicin—stomach cancer	0.000753	0.0055	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Capecitabine—stomach cancer	0.000749	0.00547	CcSEcCtD
Pyrazinamide—Discomfort—Irinotecan—stomach cancer	0.000719	0.00525	CcSEcCtD
Pyrazinamide—XDH—endocrine gland—stomach cancer	0.000705	0.0885	CbGeAlD
Pyrazinamide—Photosensitivity—Doxorubicin—stomach cancer	0.000697	0.00509	CcSEcCtD
Pyrazinamide—Myalgia—Fluorouracil—stomach cancer	0.000697	0.00509	CcSEcCtD
Pyrazinamide—Discomfort—Fluorouracil—stomach cancer	0.000688	0.00503	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Irinotecan—stomach cancer	0.000683	0.00499	CcSEcCtD
Pyrazinamide—Hepatitis—Docetaxel—stomach cancer	0.000678	0.00496	CcSEcCtD
Pyrazinamide—Anorexia—Irinotecan—stomach cancer	0.000665	0.00486	CcSEcCtD
Pyrazinamide—Hepatitis—Capecitabine—stomach cancer	0.000657	0.0048	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Fluorouracil—stomach cancer	0.000654	0.00478	CcSEcCtD
Pyrazinamide—Anorexia—Fluorouracil—stomach cancer	0.000637	0.00465	CcSEcCtD
Pyrazinamide—XDH—liver—stomach cancer	0.000636	0.0798	CbGeAlD
Pyrazinamide—AOX1—pancreas—stomach cancer	0.000635	0.0797	CbGeAlD
Pyrazinamide—Dyspepsia—Irinotecan—stomach cancer	0.000614	0.00448	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000608	0.00445	CcSEcCtD
Pyrazinamide—Decreased appetite—Irinotecan—stomach cancer	0.000606	0.00443	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000602	0.0044	CcSEcCtD
Pyrazinamide—Dyspepsia—Fluorouracil—stomach cancer	0.000588	0.0043	CcSEcCtD
Pyrazinamide—Decreased appetite—Fluorouracil—stomach cancer	0.000581	0.00424	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000577	0.00421	CcSEcCtD
Pyrazinamide—Feeling abnormal—Irinotecan—stomach cancer	0.000575	0.0042	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—stomach cancer	0.000571	0.00417	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—stomach cancer	0.000558	0.00407	CcSEcCtD
Pyrazinamide—Body temperature increased—Irinotecan—stomach cancer	0.000551	0.00403	CcSEcCtD
Pyrazinamide—Feeling abnormal—Fluorouracil—stomach cancer	0.00055	0.00402	CcSEcCtD
Pyrazinamide—AOX1—digestive system—stomach cancer	0.000543	0.0681	CbGeAlD
Pyrazinamide—Dysuria—Epirubicin—stomach cancer	0.000535	0.00391	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Capecitabine—stomach cancer	0.000531	0.00388	CcSEcCtD
Pyrazinamide—Urticaria—Fluorouracil—stomach cancer	0.000531	0.00388	CcSEcCtD
Pyrazinamide—Body temperature increased—Fluorouracil—stomach cancer	0.000528	0.00386	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Epirubicin—stomach cancer	0.000522	0.00381	CcSEcCtD
Pyrazinamide—Malaise—Capecitabine—stomach cancer	0.000516	0.00377	CcSEcCtD
Pyrazinamide—Hypersensitivity—Irinotecan—stomach cancer	0.000514	0.00375	CcSEcCtD
Pyrazinamide—Arthralgia—Docetaxel—stomach cancer	0.000503	0.00367	CcSEcCtD
Pyrazinamide—Myalgia—Docetaxel—stomach cancer	0.000503	0.00367	CcSEcCtD
Pyrazinamide—Dysuria—Doxorubicin—stomach cancer	0.000495	0.00361	CcSEcCtD
Pyrazinamide—Hypersensitivity—Fluorouracil—stomach cancer	0.000492	0.0036	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—stomach cancer	0.000489	0.00357	CcSEcCtD
Pyrazinamide—Myalgia—Capecitabine—stomach cancer	0.000487	0.00356	CcSEcCtD
Pyrazinamide—Arthralgia—Capecitabine—stomach cancer	0.000487	0.00356	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000483	0.00353	CcSEcCtD
Pyrazinamide—Discomfort—Capecitabine—stomach cancer	0.000481	0.00351	CcSEcCtD
Pyrazinamide—Pruritus—Fluorouracil—stomach cancer	0.000472	0.00345	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Docetaxel—stomach cancer	0.000472	0.00345	CcSEcCtD
Pyrazinamide—Anorexia—Docetaxel—stomach cancer	0.000459	0.00336	CcSEcCtD
Pyrazinamide—Hepatitis—Epirubicin—stomach cancer	0.000458	0.00334	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Capecitabine—stomach cancer	0.000457	0.00334	CcSEcCtD
Pyrazinamide—AOX1—endocrine gland—stomach cancer	0.000448	0.0563	CbGeAlD
Pyrazinamide—Anorexia—Capecitabine—stomach cancer	0.000445	0.00325	CcSEcCtD
Pyrazinamide—Vomiting—Irinotecan—stomach cancer	0.000443	0.00324	CcSEcCtD
Pyrazinamide—Rash—Irinotecan—stomach cancer	0.00044	0.00321	CcSEcCtD
Pyrazinamide—Dermatitis—Irinotecan—stomach cancer	0.000439	0.00321	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000439	0.00321	CcSEcCtD
Pyrazinamide—CYP1A2—hematopoietic system—stomach cancer	0.000428	0.0537	CbGeAlD
Pyrazinamide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000425	0.00311	CcSEcCtD
Pyrazinamide—Vomiting—Fluorouracil—stomach cancer	0.000425	0.0031	CcSEcCtD
Pyrazinamide—Dyspepsia—Docetaxel—stomach cancer	0.000424	0.0031	CcSEcCtD
Pyrazinamide—Hepatitis—Doxorubicin—stomach cancer	0.000423	0.00309	CcSEcCtD
Pyrazinamide—Rash—Fluorouracil—stomach cancer	0.000421	0.00308	CcSEcCtD
Pyrazinamide—Dermatitis—Fluorouracil—stomach cancer	0.000421	0.00307	CcSEcCtD
Pyrazinamide—Decreased appetite—Docetaxel—stomach cancer	0.000419	0.00306	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000416	0.00304	CcSEcCtD
Pyrazinamide—Nausea—Irinotecan—stomach cancer	0.000414	0.00303	CcSEcCtD
Pyrazinamide—Dyspepsia—Capecitabine—stomach cancer	0.000411	0.003	CcSEcCtD
Pyrazinamide—Decreased appetite—Capecitabine—stomach cancer	0.000406	0.00296	CcSEcCtD
Pyrazinamide—AOX1—liver—stomach cancer	0.000404	0.0507	CbGeAlD
Pyrazinamide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000403	0.00294	CcSEcCtD
Pyrazinamide—Feeling abnormal—Docetaxel—stomach cancer	0.000397	0.0029	CcSEcCtD
Pyrazinamide—Nausea—Fluorouracil—stomach cancer	0.000397	0.0029	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—stomach cancer	0.000395	0.00289	CcSEcCtD
Pyrazinamide—Feeling abnormal—Capecitabine—stomach cancer	0.000385	0.00281	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—stomach cancer	0.000384	0.0028	CcSEcCtD
Pyrazinamide—Body temperature increased—Docetaxel—stomach cancer	0.000381	0.00278	CcSEcCtD
Pyrazinamide—Urticaria—Capecitabine—stomach cancer	0.000371	0.00271	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Epirubicin—stomach cancer	0.00037	0.0027	CcSEcCtD
Pyrazinamide—Body temperature increased—Capecitabine—stomach cancer	0.000369	0.0027	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—stomach cancer	0.000362	0.00265	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—stomach cancer	0.000362	0.00265	CcSEcCtD
Pyrazinamide—Malaise—Epirubicin—stomach cancer	0.000359	0.00262	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—stomach cancer	0.000358	0.00262	CcSEcCtD
Pyrazinamide—Hypersensitivity—Docetaxel—stomach cancer	0.000355	0.00259	CcSEcCtD
Pyrazinamide—Hypersensitivity—Capecitabine—stomach cancer	0.000344	0.00251	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000342	0.0025	CcSEcCtD
Pyrazinamide—Pruritus—Docetaxel—stomach cancer	0.000341	0.00249	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—stomach cancer	0.00034	0.00249	CcSEcCtD
Pyrazinamide—Arthralgia—Epirubicin—stomach cancer	0.000339	0.00248	CcSEcCtD
Pyrazinamide—Myalgia—Epirubicin—stomach cancer	0.000339	0.00248	CcSEcCtD
Pyrazinamide—Discomfort—Epirubicin—stomach cancer	0.000335	0.00245	CcSEcCtD
Pyrazinamide—Malaise—Doxorubicin—stomach cancer	0.000332	0.00243	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—stomach cancer	0.000331	0.00242	CcSEcCtD
Pyrazinamide—Pruritus—Capecitabine—stomach cancer	0.00033	0.00241	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Epirubicin—stomach cancer	0.000318	0.00233	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000317	0.00231	CcSEcCtD
Pyrazinamide—Myalgia—Doxorubicin—stomach cancer	0.000314	0.00229	CcSEcCtD
Pyrazinamide—Arthralgia—Doxorubicin—stomach cancer	0.000314	0.00229	CcSEcCtD
Pyrazinamide—Discomfort—Doxorubicin—stomach cancer	0.00031	0.00227	CcSEcCtD
Pyrazinamide—AOX1—lymph node—stomach cancer	0.00031	0.0389	CbGeAlD
Pyrazinamide—Anorexia—Epirubicin—stomach cancer	0.00031	0.00226	CcSEcCtD
Pyrazinamide—CYP3A4—hematopoietic system—stomach cancer	0.00031	0.0389	CbGeAlD
Pyrazinamide—Vomiting—Docetaxel—stomach cancer	0.000306	0.00224	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—stomach cancer	0.000306	0.00223	CcSEcCtD
Pyrazinamide—Rash—Docetaxel—stomach cancer	0.000304	0.00222	CcSEcCtD
Pyrazinamide—Dermatitis—Docetaxel—stomach cancer	0.000304	0.00222	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—stomach cancer	0.000302	0.00221	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.0003	0.00219	CcSEcCtD
Pyrazinamide—CYP1A2—digestive system—stomach cancer	0.000298	0.0373	CbGeAlD
Pyrazinamide—Vomiting—Capecitabine—stomach cancer	0.000297	0.00217	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000296	0.00216	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000295	0.00215	CcSEcCtD
Pyrazinamide—Rash—Capecitabine—stomach cancer	0.000294	0.00215	CcSEcCtD
Pyrazinamide—Dermatitis—Capecitabine—stomach cancer	0.000294	0.00215	CcSEcCtD
Pyrazinamide—Anorexia—Doxorubicin—stomach cancer	0.000287	0.0021	CcSEcCtD
Pyrazinamide—Nausea—Docetaxel—stomach cancer	0.000286	0.00209	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—stomach cancer	0.000286	0.00209	CcSEcCtD
Pyrazinamide—Dyspepsia—Epirubicin—stomach cancer	0.000286	0.00209	CcSEcCtD
Pyrazinamide—Decreased appetite—Epirubicin—stomach cancer	0.000283	0.00207	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000281	0.00205	CcSEcCtD
Pyrazinamide—Nausea—Capecitabine—stomach cancer	0.000277	0.00203	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—stomach cancer	0.000276	0.00202	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—stomach cancer	0.000275	0.00201	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000274	0.002	CcSEcCtD
Pyrazinamide—Feeling abnormal—Epirubicin—stomach cancer	0.000268	0.00196	CcSEcCtD
Pyrazinamide—Dyspepsia—Doxorubicin—stomach cancer	0.000265	0.00193	CcSEcCtD
Pyrazinamide—Decreased appetite—Doxorubicin—stomach cancer	0.000261	0.00191	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00026	0.0019	CcSEcCtD
Pyrazinamide—Urticaria—Epirubicin—stomach cancer	0.000258	0.00189	CcSEcCtD
Pyrazinamide—Body temperature increased—Epirubicin—stomach cancer	0.000257	0.00188	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—stomach cancer	0.000256	0.00187	CcSEcCtD
Pyrazinamide—Feeling abnormal—Doxorubicin—stomach cancer	0.000248	0.00181	CcSEcCtD
Pyrazinamide—CYP1A2—endocrine gland—stomach cancer	0.000246	0.0309	CbGeAlD
Pyrazinamide—Pruritus—Methotrexate—stomach cancer	0.000246	0.0018	CcSEcCtD
Pyrazinamide—Hypersensitivity—Epirubicin—stomach cancer	0.00024	0.00175	CcSEcCtD
Pyrazinamide—Urticaria—Doxorubicin—stomach cancer	0.000239	0.00175	CcSEcCtD
Pyrazinamide—Body temperature increased—Doxorubicin—stomach cancer	0.000238	0.00174	CcSEcCtD
Pyrazinamide—Pruritus—Epirubicin—stomach cancer	0.00023	0.00168	CcSEcCtD
Pyrazinamide—CYP1A2—liver—stomach cancer	0.000222	0.0278	CbGeAlD
Pyrazinamide—Hypersensitivity—Doxorubicin—stomach cancer	0.000222	0.00162	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—stomach cancer	0.000221	0.00161	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—stomach cancer	0.000219	0.0016	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—stomach cancer	0.000219	0.0016	CcSEcCtD
Pyrazinamide—CYP3A4—digestive system—stomach cancer	0.000215	0.027	CbGeAlD
Pyrazinamide—Pruritus—Doxorubicin—stomach cancer	0.000213	0.00156	CcSEcCtD
Pyrazinamide—Vomiting—Epirubicin—stomach cancer	0.000207	0.00151	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—stomach cancer	0.000206	0.00151	CcSEcCtD
Pyrazinamide—Rash—Epirubicin—stomach cancer	0.000205	0.0015	CcSEcCtD
Pyrazinamide—Dermatitis—Epirubicin—stomach cancer	0.000205	0.0015	CcSEcCtD
Pyrazinamide—Nausea—Epirubicin—stomach cancer	0.000193	0.00141	CcSEcCtD
Pyrazinamide—Vomiting—Doxorubicin—stomach cancer	0.000191	0.0014	CcSEcCtD
Pyrazinamide—Rash—Doxorubicin—stomach cancer	0.00019	0.00139	CcSEcCtD
Pyrazinamide—Dermatitis—Doxorubicin—stomach cancer	0.000189	0.00138	CcSEcCtD
Pyrazinamide—XDH—Metabolism—PLIN2—stomach cancer	0.000183	0.00178	CbGpPWpGaD
Pyrazinamide—Nausea—Doxorubicin—stomach cancer	0.000179	0.00131	CcSEcCtD
Pyrazinamide—CYP3A4—endocrine gland—stomach cancer	0.000178	0.0223	CbGeAlD
Pyrazinamide—AOX1—Metabolism—ALDH7A1—stomach cancer	0.000178	0.00173	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PLCE1—stomach cancer	0.000178	0.00173	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CA2—stomach cancer	0.000178	0.00173	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NT5E—stomach cancer	0.000173	0.00169	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PGAM1—stomach cancer	0.000173	0.00169	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000171	0.00167	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—UMPS—stomach cancer	0.00017	0.00166	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALDH7A1—stomach cancer	0.000165	0.00161	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLCE1—stomach cancer	0.000165	0.00161	CbGpPWpGaD
Pyrazinamide—CYP3A4—liver—stomach cancer	0.00016	0.0201	CbGeAlD
Pyrazinamide—AOX1—Metabolism—PDHA1—stomach cancer	0.000158	0.00154	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ECHS1—stomach cancer	0.000158	0.00154	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—UMPS—stomach cancer	0.000158	0.00154	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ALDOB—stomach cancer	0.000154	0.0015	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000154	0.0015	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPL15—stomach cancer	0.000151	0.00147	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—FADS1—stomach cancer	0.000149	0.00145	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TYMP—stomach cancer	0.000149	0.00145	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NPM1—stomach cancer	0.000148	0.00145	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PDHA1—stomach cancer	0.000147	0.00144	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ECHS1—stomach cancer	0.000147	0.00144	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RBP4—stomach cancer	0.000143	0.0014	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTP1—stomach cancer	0.000141	0.00138	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPS26—stomach cancer	0.000141	0.00137	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PPIA—stomach cancer	0.00014	0.00136	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SREBF2—stomach cancer	0.000139	0.00136	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TYMP—stomach cancer	0.000138	0.00135	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—FADS1—stomach cancer	0.000138	0.00135	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—RORA—stomach cancer	0.000138	0.00134	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—GSTM1—stomach cancer	0.00013	0.00127	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SREBF2—stomach cancer	0.00013	0.00126	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALDOB—stomach cancer	0.000129	0.00126	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—RORA—stomach cancer	0.000128	0.00125	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	0.000123	0.0012	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALOX5—stomach cancer	0.00012	0.00117	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALDOB—stomach cancer	0.00012	0.00117	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPS19—stomach cancer	0.00012	0.00117	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKR1C3—stomach cancer	0.00012	0.00117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTT1—stomach cancer	0.000119	0.00116	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—DPYD—stomach cancer	0.000118	0.00115	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP2A6—stomach cancer	0.000118	0.00115	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ENO1—stomach cancer	0.000117	0.00114	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000117	0.00114	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000117	0.00114	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000115	0.00112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.000115	0.00112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	0.000113	0.0011	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALOX5—stomach cancer	0.000112	0.00109	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	0.000111	0.00108	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—DPYD—stomach cancer	0.00011	0.00107	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000108	0.00105	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPS6—stomach cancer	0.000106	0.00103	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTT1—stomach cancer	0.000104	0.00102	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD44—stomach cancer	0.000104	0.00101	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP2A6—stomach cancer	0.000103	0.00101	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000103	0.001	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKR1C3—stomach cancer	0.0001	0.000979	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ENO1—stomach cancer	9.78e-05	0.000954	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HBEGF—stomach cancer	9.74e-05	0.00095	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTT1—stomach cancer	9.71e-05	0.000946	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	9.7e-05	0.000946	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2A6—stomach cancer	9.6e-05	0.000936	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKR1C3—stomach cancer	9.33e-05	0.00091	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTT1—stomach cancer	9.21e-05	0.000898	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	9.11e-05	0.000888	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ENO1—stomach cancer	9.1e-05	0.000887	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	8.92e-05	0.00087	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PPP2R1A—stomach cancer	8.81e-05	0.000859	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	8.74e-05	0.000852	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	8.73e-05	0.000851	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	8.73e-05	0.000851	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	8.73e-05	0.000851	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CD44—stomach cancer	8.68e-05	0.000846	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	8.63e-05	0.000841	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	8.31e-05	0.000811	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	8.31e-05	0.000811	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTP1—stomach cancer	8.28e-05	0.000807	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	8.25e-05	0.000804	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SMAD4—stomach cancer	8.18e-05	0.000798	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	8.16e-05	0.000796	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CD44—stomach cancer	8.07e-05	0.000787	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FYN—stomach cancer	7.77e-05	0.000757	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—stomach cancer	7.6e-05	0.000742	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	7.5e-05	0.000731	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERCC2—stomach cancer	7.47e-05	0.000728	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPP2R1A—stomach cancer	7.38e-05	0.000719	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGFR2—stomach cancer	7.29e-05	0.000711	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTP1—stomach cancer	7.24e-05	0.000706	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMOX1—stomach cancer	7.14e-05	0.000696	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ACAD8—stomach cancer	7.11e-05	0.000694	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTHFR—stomach cancer	7.02e-05	0.000684	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	7.01e-05	0.000683	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	6.95e-05	0.000678	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPP2R1A—stomach cancer	6.86e-05	0.000669	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TYMS—stomach cancer	6.73e-05	0.000656	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTP1—stomach cancer	6.73e-05	0.000656	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IRS2—stomach cancer	6.68e-05	0.000651	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—stomach cancer	6.65e-05	0.000648	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMOX1—stomach cancer	6.64e-05	0.000647	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	6.54e-05	0.000637	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CAV1—stomach cancer	6.47e-05	0.000631	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOA1—stomach cancer	6.46e-05	0.00063	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTP1—stomach cancer	6.39e-05	0.000623	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GMPR2—stomach cancer	6.34e-05	0.000618	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.3e-05	0.000614	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TYMS—stomach cancer	6.26e-05	0.00061	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ERCC2—stomach cancer	6.25e-05	0.00061	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—stomach cancer	6.18e-05	0.000603	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6ST—stomach cancer	6.14e-05	0.000598	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	6.12e-05	0.000597	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	6.05e-05	0.00059	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APC—stomach cancer	5.9e-05	0.000575	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—stomach cancer	5.88e-05	0.000573	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—stomach cancer	5.87e-05	0.000572	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ERCC2—stomach cancer	5.81e-05	0.000567	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—IDH3B—stomach cancer	5.8e-05	0.000566	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SUCLG1—stomach cancer	5.8e-05	0.000566	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	5.79e-05	0.000564	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ACAD8—stomach cancer	5.49e-05	0.000535	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6R—stomach cancer	5.48e-05	0.000534	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—stomach cancer	5.46e-05	0.000533	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CAV1—stomach cancer	5.42e-05	0.000529	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOA1—stomach cancer	5.41e-05	0.000527	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NDUFS1—stomach cancer	5.39e-05	0.000526	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NDUFV1—stomach cancer	5.39e-05	0.000526	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	5.27e-05	0.000514	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—stomach cancer	5.13e-05	0.0005	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAV1—stomach cancer	5.04e-05	0.000491	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA1—stomach cancer	5.03e-05	0.00049	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RHOA—stomach cancer	4.95e-05	0.000482	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—stomach cancer	4.9e-05	0.000477	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GMPR2—stomach cancer	4.89e-05	0.000477	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BLVRB—stomach cancer	4.81e-05	0.000469	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PGLS—stomach cancer	4.81e-05	0.000469	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARG—stomach cancer	4.77e-05	0.000465	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPAP2A—stomach cancer	4.58e-05	0.000447	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB2—stomach cancer	4.58e-05	0.000446	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—stomach cancer	4.48e-05	0.000437	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—IDH3B—stomach cancer	4.48e-05	0.000436	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.48e-05	0.000436	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARG—stomach cancer	4.43e-05	0.000432	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.41e-05	0.00043	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—stomach cancer	4.29e-05	0.000418	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1B—stomach cancer	4.24e-05	0.000413	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.16e-05	0.000406	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.16e-05	0.000406	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—stomach cancer	4.1e-05	0.0004	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CKB—stomach cancer	4.09e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA1—stomach cancer	4.09e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NDUFA2—stomach cancer	4.09e-05	0.000398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FBP1—stomach cancer	4.09e-05	0.000398	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—stomach cancer	3.98e-05	0.000388	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1A—stomach cancer	3.91e-05	0.000382	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLIN2—stomach cancer	3.84e-05	0.000375	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—stomach cancer	3.81e-05	0.000372	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—stomach cancer	3.75e-05	0.000366	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA2—stomach cancer	3.74e-05	0.000364	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PGLS—stomach cancer	3.71e-05	0.000362	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BLVRB—stomach cancer	3.71e-05	0.000362	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NT5E—stomach cancer	3.64e-05	0.000355	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PGAM1—stomach cancer	3.64e-05	0.000355	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.54e-05	0.000345	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—stomach cancer	3.49e-05	0.00034	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—stomach cancer	3.49e-05	0.00034	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLCE1—stomach cancer	3.47e-05	0.000339	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH7A1—stomach cancer	3.47e-05	0.000339	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—stomach cancer	3.34e-05	0.000325	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UMPS—stomach cancer	3.33e-05	0.000325	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MYC—stomach cancer	3.24e-05	0.000316	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK1—stomach cancer	3.17e-05	0.00031	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—stomach cancer	3.17e-05	0.000309	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.15e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CKB—stomach cancer	3.15e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FBP1—stomach cancer	3.15e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA1—stomach cancer	3.15e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ECHS1—stomach cancer	3.1e-05	0.000302	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PDHA1—stomach cancer	3.1e-05	0.000302	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KRAS—stomach cancer	3e-05	0.000292	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLIN2—stomach cancer	2.97e-05	0.000289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TYMP—stomach cancer	2.91e-05	0.000284	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FADS1—stomach cancer	2.91e-05	0.000284	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA2—stomach cancer	2.88e-05	0.000281	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PGAM1—stomach cancer	2.81e-05	0.000274	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NT5E—stomach cancer	2.81e-05	0.000274	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—stomach cancer	2.75e-05	0.000269	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SREBF2—stomach cancer	2.73e-05	0.000266	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—RORA—stomach cancer	2.69e-05	0.000263	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLCE1—stomach cancer	2.68e-05	0.000261	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.68e-05	0.000261	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UMPS—stomach cancer	2.57e-05	0.000251	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HRAS—stomach cancer	2.55e-05	0.000248	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDOB—stomach cancer	2.52e-05	0.000246	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—stomach cancer	2.44e-05	0.000238	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PDHA1—stomach cancer	2.39e-05	0.000233	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ECHS1—stomach cancer	2.39e-05	0.000233	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.38e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.38e-05	0.000232	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALOX5—stomach cancer	2.35e-05	0.000229	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DPYD—stomach cancer	2.31e-05	0.000225	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—stomach cancer	2.31e-05	0.000225	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TYMP—stomach cancer	2.25e-05	0.000219	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FADS1—stomach cancer	2.25e-05	0.000219	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—stomach cancer	2.14e-05	0.000209	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SREBF2—stomach cancer	2.1e-05	0.000205	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.09e-05	0.000204	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—RORA—stomach cancer	2.08e-05	0.000203	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—stomach cancer	2.04e-05	0.000199	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.02e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.96e-05	0.000191	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDOB—stomach cancer	1.95e-05	0.00019	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ENO1—stomach cancer	1.91e-05	0.000187	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.88e-05	0.000183	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALOX5—stomach cancer	1.81e-05	0.000177	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DPYD—stomach cancer	1.78e-05	0.000174	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CD44—stomach cancer	1.7e-05	0.000165	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.65e-05	0.000161	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—stomach cancer	1.58e-05	0.000154	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.56e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.52e-05	0.000148	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ENO1—stomach cancer	1.48e-05	0.000144	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.44e-05	0.000141	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—stomach cancer	1.42e-05	0.000138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—stomach cancer	1.4e-05	0.000136	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TYMS—stomach cancer	1.32e-05	0.000128	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CD44—stomach cancer	1.31e-05	0.000128	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—stomach cancer	1.3e-05	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ERCC2—stomach cancer	1.22e-05	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—stomach cancer	1.15e-05	0.000112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.11e-05	0.000109	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—stomach cancer	1.09e-05	0.000106	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—stomach cancer	1.08e-05	0.000105	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAV1—stomach cancer	1.06e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA1—stomach cancer	1.06e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TYMS—stomach cancer	1.02e-05	9.9e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—stomach cancer	1e-05	9.79e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ERCC2—stomach cancer	9.44e-06	9.2e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARG—stomach cancer	9.32e-06	9.09e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—stomach cancer	8.87e-06	8.65e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—stomach cancer	8.38e-06	8.17e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAV1—stomach cancer	8.18e-06	7.98e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA1—stomach cancer	8.16e-06	7.96e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—stomach cancer	8.02e-06	7.82e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—stomach cancer	7.33e-06	7.15e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARG—stomach cancer	7.19e-06	7.01e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—stomach cancer	6.47e-06	6.31e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—stomach cancer	6.19e-06	6.03e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—stomach cancer	5.66e-06	5.52e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—stomach cancer	4.51e-06	4.4e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.48e-06	3.39e-05	CbGpPWpGaD
